Literature DB >> 27631606

Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.

A T Cohen, M Hamilton, A Bird, S A Mitchell, X Li, R Horblyuk, S Batson.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0160064.].

Entities:  

Year:  2016        PMID： 27631606      PMCID： PMC5025275          DOI： 10.1371/journal.pone.0163386

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The fifth authors name is spelled incorrectly. The correct name is Xiaoyan Li. The correct citation is: Cohen AT, Hamilton M, Bird A, Mitchell SA, Li X, Horblyuk R, et al. (2016) Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS ONE 11(8): e0160064. doi:10.1371/journal.pone.0160064
  1 in total

Review 1.  Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.

Authors:  A T Cohen; M Hamilton; A Bird; S A Mitchell; S Li; R Horblyuk; S Batson
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240
  1 in total
  2 in total

1.  Warfarin versus factor Xa inhibitors in the long-term treatment of cerebral venous sinus thrombosis a single-center retrospective analysis.

Authors:  Alexei Christodoulides; Bradley N Bohnstedt
Journal:  eNeurologicalSci       Date:  2022-06-17

2.  Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation.

Authors:  Elias Kyriakou; Konstantinos Katogiannis; Ignatios Ikonomidis; George Giallouros; Georgios K Nikolopoulos; Evdoxia Rapti; Maria Taichert; Katerina Pantavou; Argiri Gialeraki; Foteini Kousathana; Aristarchos Poulis; Andreas G Tsantes; Stefanos Bonovas; Violetta Kapsimali; Georgios Tsivgoulis; Argirios E Tsantes
Journal:  Clin Appl Thromb Hemost       Date:  2018-10-01       Impact factor: 2.389
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.